AngioDynamics

AngioDynamics Debt

The Debt of AngioDynamics (ANGO) as of Sep 20, 2026 is 6.20 M USD.

Debt

6.20 MUSD

Last updated:

In 2026, AngioDynamics's total debt was 6.20 M USD, a % change from the 0.00 USD total debt recorded in the previous year.

The AngioDynamics Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
91.60 M USD
Jan 1, 2019
131.90 M USD
Jan 1, 2020
40.00 M USD
Jan 1, 2021
20.00 M USD
Jan 1, 2022
25.00 M USD
Jan 1, 2023
49.80 M USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
6.20 M USD
The AngioDynamics Debt history
YEARDebtYoY
6.20 MUSD
0.00USD-100.00%
49.80 MUSD+99.20%
25.00 MUSD+25.00%
20.00 MUSD-50.00%
40.00 MUSD-69.67%
131.90 MUSD+44.00%
91.60 MUSD-4.88%
96.30 MUSD-20.08%
120.50 MUSD-12.49%
137.70 MUSD-3.50%
142.70 MUSD
Access this data via the Eulerpool API

AngioDynamics Stock analysis

What does AngioDynamics do? AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics focuses on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the Vascular Access Solutions division, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary for the treatment of serious illnesses. This includes port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment options, including ultrasound-controlled radiofrequency ablation systems and fusion biopsy systems. The development of innovative diagnostic and treatment options is a focus of AngioDynamics. A majority of AngioDynamics' products are in the Peripheral Vascular Solutions division. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases such as varicose veins or chronic venous insufficiency. This includes procedures like laser and radiofrequency treatments that can be performed minimally invasively. AngioDynamics has gained an excellent reputation in the medical industry due to its high-quality products, innovative technologies, and close collaboration with medical professionals. The company places great emphasis on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Over the years, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products. AngioDynamics is one of the most popular companies on Eulerpool.

Debt Details

Understanding AngioDynamics's Debt Structure

AngioDynamics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing AngioDynamics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to AngioDynamics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in AngioDynamics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about AngioDynamics stock

Debt of AngioDynamics is 6.20 M USD in 2026.

On Eulerpool you can find the complete historical development of Debt AngioDynamics since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's AngioDynamics historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — AngioDynamics

All Key Metrics — AngioDynamics